This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
We aim to give pharmacists the tools they need to contribute meaningfully to cancer care, says Professor Meier, and this structured approach underscores the specialisms role within the broader hospital pharmacy framework, as well as its pivotal contribution to multidisciplinary cancer care teams.
Patient recruitment often required participants to travel to trial sites, like hospitals or research centers, creating barriers due to geographic distance, travel costs, and time away from daily obligations. Regular workshops can ensure alignment and make your digital integration smoother.
These concepts were then further evaluated during a workshop with specialty pharmacy stakeholders, during which turnaround time emerged as a high priority for measure development. ready for pick up or scheduled for delivery). Differring patient needs or preferences require different coordinated approaches.
Summary from Advanced Manufacturing Technology Workshop Held at 6th Accelerating Biopharmaceutical Development Meeting.” Subsequently, the new data is authored into Module 3 (Quality) of the Common Technical Document and submitted separately to multiple health authorities worldwide for approval. Advanced Manufacturing.” 7 June 2023.
The COVID-19 pandemic underscores the importance of DHTs through the increased reliance on telemedicine services and remote patient monitoring programs to ensure patient safety and triage scarce hospital resources. 2021 Workshop Report–Digital Technologies for Clinical Evidence Generation.” IMDRF SaMD Risk Categorization. Framework 26.
The COVID-19 pandemic underscores the importance of DHTs through the increased reliance on telemedicine services and remote patient monitoring programs to ensure patient safety and triage scarce hospital resources. 2021 Workshop Report–Digital Technologies for Clinical Evidence Generation.” IMDRF SaMD Risk Categorization. Framework 26.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content